Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:10 July,2020

Rapid antigen tests soon at dispensaries, polyclinics in Delhi

NEW DELHI: A day after it asked the districts to carry out focused testing in corona-prone areas outside the containment zones and hotspots, Delhi government on Thursday decided to open its dispensaries and polyclinics for eligible individuals to walk in for rapid antigen testing. ,An order issued by the directorate general of health services said, the dispensaries and clinics will remain open between 9am and 12 noon on all working days.
The DGHS has also assigned responsibilities to different districts to carry out focused testing of high-risk and special surveillance groups in different areas. ....read more

CMAAO Coronavirus Facts and Myth Buster: Managing COVID-19 - Recovery is the rule

Round Table Expert Zoom Meeting on “Recovery is the rule in COVID-19 and death is an exception”
Participants: Dr KK Aggarwal, Dr Shashank Joshi, Prof Mahesh Verma, Dr Ashok Gupta, Dr Suneela Garg, Dr JA Jayalal, Dr Jayakrishnan AV, Dr Alex Thomas, Dr Shiv K Harti, Vaidya Sushil Dubey, Mrs Upasana Arora, Dr K Kalra, Ms Ira Gupta, Dr S Sharma
Key points from the discussion:Timely action can save lives as most cases are mild; few are moderate and less than 5% are serious. ,Death rate is reducing as we are now able to better manage cases. ,In all patients who have loss of smell/taste, recovery is the rule and mortality is an exception. Analysis of 100 patients with loss of smell/taste showed that none needed oxygen or ventilator or hospitalization. It occurred more often in males, at any age and recovery is the rule within 4 weeks. ....read more

World Covid Meter 9th July: India Number 3, 213 Countries Affected

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29, 11M July 4, 12M July 8
Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Doubling time India 21 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days ,Likely minimum deaths (552023 + 58319 x 15 == 8748) = 560770,Coronavirus Cases: 12,164,11,Deaths: 552,023,Recovered: 7,030,006,ACTIVE CASES: 4,582,090 ....read more

Soul does not leave the body immediately after the death

According to Prashna Upanishad, at the time of death, the Prana Vayu (life force and respiration) merges with Udana Vayu (brain stem reflexes) and leaves the body. But this does not happen immediately after clinical death, which is defined as stoppage of heart and respiration. Medically, the term used for clinically dead patients is sudden cardiac arrest.
As per modern medicine, in cardiac arrest, the brain does not die for the next 10 minutes and during this period, if the heart can be revived, life can be brought back. ,The revival of patient during this period can be remembered by the ‘Formula of 10’: Within 10 minutes of the stoppage of heart (cardiac arrest), if effective chest compressions are given for the next ten minutes with a speed of 100 per minute (10X10), 80% of the cardiac arrest victims can be revived. ....read more

Video of The day

Why in some COVID Fever lasts More than 21 days



Healthcare News Monitor
Indian pharma industry committed to supply of quality drugs in India, world: IPA

NEW DELHI : Indian pharma industry is committed to an uninterrupted supply of quality medicines to patients in India and globally, Indian Pharmaceutical Alliance (IPA) said on Thursday.
“The Prime Minister's speech at the India Global Week 2020 captures the strength of India's pharma industry. During these unprecedented times, the pharmaceutical industry worked in an integrated manner with the Indian government to ensure fulfilling domestic demand and meet export obligations and truly lived up to its title as the 'Pharmacy of the World'," IPA Secretary General Sudarshan Jain said in a statement.

Cipla’s First Batch of Remdesivir dispatched from Sovereign Pharma
Manufacturing Today India

As Indian medical authorities and the pharma industry are working relentlessly to provide medications to treat Coronavirus, Sovereign Pharma announced the dispatch of its first batch of Remdesivir injections for Cipla recently.
In absence of a definitive line of treatment, the Indian government under The Prime Minister Narendra Modi has been instrumental in encouraging local drug manufacturers to identify potential treatments for the virus, as well as to ramp up production of the existing medications. Within the union territory of Daman and Diu, one of India’s pharmaceutical hubs, Sovereign Pharma has prepared the first batch of Remdesivir within record time. Under the guidance of The Hon’ble Administrator Praful Patel, the facility recently went through a meticulous inspection by the CDSCO and received necessary approvals from the authority within a week.

His name on Ben Stokes’s jersey, Dr. Vikas Kumar of Indian origin is ‘overwhelmed’
The Indian Express

TILL ABOUT 48 hours ago, the closest that Dr Vikas Kumar had come to his schoolboy dream of playing top-level cricket was when he was appointed “Doctor on Duty” at the Feroz Shah Kotla in Delhi for the India-Sri Lanka Test match three years ago.
On Wednesday morning, the 35-year-old had his name on an England shirt. ,As international cricket resumed in Southampton after a gap of 117 days, Kumar’s name was among those featured on the jerseys of England’s Test players to honour health workers at the forefront of the Covid fight. Kumar works at the critical care unit of a National Health Service (NHS) Trust hospital at Darlington in Durham, and was among those nominated by cricket clubs in England as part of their Raise The Bat campaign. For him, the topping on the treat was when his name featured on the jersey worn by England’s captain and World Cup star Ben Stokes.

ET Health

WASHINGTON: The Ayurvedic practitioners and researchers in India and the US are planning to initiate joint clinical trials for Ayurveda formulations against the novel coronavirus, the Indian envoy here has said.
In a virtual interaction with a group of eminent Indian-American scientists, academicians, and doctors on Wednesday, Indian Ambassador to the US Taranjit Singh Sandhu said the vast network of institutional engagements have brought scientific communities between the two countries together in the fight against COVID-19.
“Our Institutions have also been collaborating to promote Ayurveda through joint research, teaching and training programmes. The Ayurvedic practitioners and researchers in both the countries are planning to initiate joint clinical trials of Ayurvedic formulations against COVID-19,” Sandhu said.